Conference abstractPublished 22 May 2017
Cardio-oncology: Cure the cancer and protect the heart
University of Illinois Hospital & Health Sciences, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Major therapeutic strides have been accomplished in oncology. Perhaps one of the best has been in breast cancer. Approximately, 3 million women are breast cancer survivors. However, there is a dark side to that statistic. Instead of women dying of breast cancer, data suggest that these women are dying of cardiovascular disease. Depending on the type of therapy, women can be up to 7 times more likely to develop cardiomyopathy compared to women who doesn’t receive cardiotoxic therapy. The epidemiology data and clinical research are changing the paradigm of cardiotoxicity in cancer therapy. Recently, the American Society of Clinical Oncology published recommendations on the prevention and management of cancer patients undergoing cardiotoxic therapies. Risk factor assessment, imaging and biomarkers have emerged as new strategies to assess and manage these patients. Perhaps, the most intriguing data that has been published in this arena is the use of global longitudinal strain (GLS). Measurement of GLS has demonstrated the ability to predict negative cardiac outcomes. It has the ability to detect subclinical damage to the heart. This concept is radically different than our historic methods of detecting cardiotoxicity. Historically, the preferred and most accepted imaging has been the multigated acquisition or MUGA. However, this time of imaging has limitations, in particular, the ability to detect subclinical cardiotoxicity. It can only detect cardiotoxicity that has already resulted in decline in ejection fraction. This presentation will discuss the epidemiology of cardiotoxicity in cancer patients and discuss the emerging strategies to detect, prevent and manage cardiotoxicity.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Trials
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sandra Cuellar”
